Heparin Induced Thrombocytopenia (HIT) is a life-and-limb threatening potential complication of Heparin therapy. An immune-mediated condition where antibodies to complexes of Heparin/Platelet Factor 4 (PF4) play a major role in the pathogenesis, HIT is often seen in patients on Heparin post cardiac or orthopedic surgery.
Rule out tests such as PIFA Heparin/PF4™ are rapidly becoming a standard of care. PIFA Heparin/PF4™ is a simple, cost-effective immunoassay for the qualitative detection of antibodies to PF4-sensitized microspheres.
Ruling out PF4 antibodies rapidly enables clinicians to avoid unnecessary heparin discontinuation and use of alternative anticoagulant therapies, such as Direct Thrombin Inhibitors (DTIs) that can result in:
Ideal for labs of all sizes, PIFA Heparin/PF4™ offers several advantages:
|PIFA Heparin/PF4™ (serum) Devices (6 tests/pack)||4036025|
|PIFA Heparin/PF4™ (serum) – Controls, 6 Panel (5 Pos/1 Neg)||4036028|
|PIFA Heparin/PF4™ (serum) – Controls, 2 Panel (1 Pos/1 Neg)||4036027|